Translate Bio Inc

+0.56 (+2.91%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.49B
Current PEN/A
Forward PE N/A
2yr Forward PE 17.99
See more stats
Estimates Current Quarter
Revenue$42.72 Million
Adjusted EPS-$0.03
See more estimates
10-Day MA$18.75
50-Day MA$21.07
200-Day MA$18.61
See more pivots

Translate Bio Inc Stock, NASDAQ:TBIO

29 Hartwell Avenue, 29 Hartwell Avenue, Lexington, Massachusetts 02421
United States of America
Phone: +1.617.945.7361
Number of Employees: 122


Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA.